Does newborn screening save money? The difference between cost-effective and cost-saving interventions.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Jornal de Pediatria

• Publication date

  2005-02-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1016/J.JPEDS.2004.10.015PMID 15689900
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical-effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: A systematic review

  2004cited by this paper
• A systematic review of the role of bisphosphonates in metastatic disease.

  2004cited by this paper
• Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003.

  2004cited by this paper
• Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.

  2003cited by this paper
• Long-term developmental outcomes of children identified through a newborn screening program with a metabolic or endocrine disorder: a population-based approach.

  2003cited by this paper
• Using survey data to study disability : results from the national health interview survey on disability

  2003cited by this paper
• Genetic screening of newborns.

  2003cited by this paper
• Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.

  2002cited by this paper
• Newborn screening with tandem mass spectrometry: examining its cost-effectiveness in the Wisconsin Newborn Screening Panel.

  2002cited by this paper
• Economic Costs of Mental Retardation, Cerebral Palsy, Hearing Loss, and Vision Impairment: Using Survey Data to Study Disability: Results from the National Health Interview Survey on Disability

  2002cited by this paper
• The Impact of the Medicaid Expansions for Pregnant Women: A Synthesis of the Evidence

  2001cited by this paper
• Priorities among recommended clinical preventive services.

  2001cited by this paper
• Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults 1 2

  2000cited by this paper
• Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services.

  2000cited by this paper
• Universal versus targeted screening of infants for sickle cell disease: a cost-effectiveness analysis.

  2000cited by this paper
• Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria.

  1999cited by this paper
• A cost-effectiveness evaluation of newborn hemoglobinopathy screening from the perspective of state health care systems.

  1996cited by this paper
• For every dollar spent--the cost-savings argument for prenatal care.

  1994cited by this paper
• The cost effectiveness of prenatal care in reducing low birth weight in New Hampshire.

  1989cited by this paper
• Healthy Children: Investing in the Future Office of Technology Assessment

  1988cited by this paper
• Use and misuse of the term "cost effective" in medicine.

  1986cited by this paper
• Congenital hypothyroidism control programs. A cost-benefit analysis.

  1979cited by this paper

• Data-Related and Methodological Challenges in Assessing the Cost-Effectiveness of Traditional and Genomic Newborn Screening Programs

  2025cites this paper
• Revolutionizing neonatal health: India's journey from assays to advanced genetics.

  2025cites this paper
• Tiny patients, huge impact: a call to action

  2024cites this paper
• [Disease spectrum and pathogenic genes of inherited metabolic disorder in Gansu Province of China].

  2024cites this paper
• Newborn Screening for Congenital Hypothyroidism and Phenylketonuria-Beyond Cost Savings.

  2023cites this paper
• [Newborn screening for congenital hypothyroidism and congenital adrenal hyperplasia: Benefits and costs of a successful public health program].

  2021cites this paper
• Newborn screening for congenital hypothyroidism and congenital adrenal hyperplasia: the balance of benefits and costs of a public health success

  2021cites this paper
• Identifying and overcoming barriers to harmonize newborn screening programs through consensus strategies

  2020cites this paper
• The Methodological Quality and Challenges in Conducting Economic Evaluations of Newborn Screening: A Scoping Review

  2020cites this paper
• Congenital Hypothyroidism: 8-Year Experience Using 2 Newborn Screens in Alabama

  2019cites this paper
• Introducing a reserve waiting list initiative for elective general surgery at a District General Hospital

  2019cites this paper
• What Contribution Did Economic Evidence Make to the Adoption of Universal Newborn Hearing Screening Policies in the United States?

  2018cites this paper
• Newborn Screening: History, Current Status, and Future Directions.

  2018cites this paper
• Newborn Screening: Beyond the Spot.

  2017cites this paper
• Are lower TSH cutoffs in neonatal screening for congenital hypothyroidism warranted?

  2017cites this paper
• Challenges for Worldwide Harmonization of Newborn Screening Programs.

  2016cites this paper
• Routine Screening Ultrasound in Children With Cleft Palate and/or Lip: A Single Center Experience

  2016cites this paper
• Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis

  2015cites this paper
• Cost-benefit analysis of Hyperphenylalaninemia Due to 6-Pyruvoyl-Tetrahydropterin Synthase (PTPS) Deficiency: For Consideration of Expanded Newborn Screening in Hong Kong

  2014cites this paper
• Newborn screening.

  2014cites this paper
• Nutritional Management of Aminoacidopathies in Saudi Arabia

  2014cites this paper
• Impact of observed versus hypothesized service utilization on the incremental cost of first trimester screening and prenatal diagnosis for trisomy 21 in a Canadian province

  2013cites this paper
• Expanded newborn screening and confirmatory follow-up testing for inborn errors of metabolism detected by tandem mass spectrometry

  2013cites this paper
• Impact of prenatal screening on future resource utilization in pregnancy

  2012cites this paper
• Newborn screening and renal disease: where we have been; where we are now; where we are going

  2012cites this paper
• Evaluation of current guthrie TSH cut-off point in Iran congenital hypothyroidism screening program: a cost-effectiveness analysis.

  2012cites this paper
• Expansion of the New York State Newborn Screening Panel and Krabbe Disease: A Systematic Program Evaluation

  2011cites this paper
• Dépistage de la phénylcétonurie

  2011cites this paper
• Newborn Screening

  2011cites this paper
• Pediatricians’ Attitudes About Screening Newborns for Infectious Diseases

  2010cites this paper
• No Follow-Up After Positive Newborn Screening: Medical Neglect?

  2010cites this paper
• What is the value for money of prenatal carrier screening for spinal muscular atrophy? Too soon to say.

  2010cites this paper
• Screening for Phenylketonuria

  2010cites this paper
• Detección sistemática de la fenilcetonuria

  2010cites this paper
• CHAPTER 41 – Genomics and Population Screening: Example of Newborn Screening

  2009cites this paper
• Newborn screening for all identifiable disorders with tandem mass spectrometry is cost effective: supporting arguments.

  2008cites this paper
• Issues on universal screening for galactosemia.

  2008cites this paper
• Chapter 1 Newborn Screening for Intellectual Disability

  2008cites this paper
• MMP-2, TIMP-2 and CD44v6 expression in non-small-cell lung carcinomas.

  2008cites this paper
• Lessons from cost-effectiveness research for United States public health policy.

  2007cites this paper
• Newborn screening for intellectual disability: Past, present, and future:

  2007cites this paper
• Galactosemia : the South African study

  2006cites this paper
• Newborn screening for metabolic disorders.

  2006cites this paper
• From Public Health Emergency to Public Health Service: The Implications of Evolving Criteria for Newborn Screening Panels

  2006cites this paper
• A primer on economic evaluations related to expansion of newborn screening for genetic and metabolic disorders.

  2006cites this paper
• Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis.

  2006cites this paper
• Newborn screening for developmental disabilities: reframing presumptive benefit.

  2005cites this paper